207 related articles for article (PubMed ID: 28851916)
1. A novel three-dimensional culture system maintaining the physiological extracellular matrix of fibrotic model livers accelerates progression of hepatocellular carcinoma cells.
Miyauchi Y; Yasuchika K; Fukumitsu K; Ishii T; Ogiso S; Minami T; Kojima H; Yamaoka R; Katayama H; Kawai T; Yoshitoshi-Uebayashi EY; Kita S; Yasuda K; Sasaki N; Uemoto S
Sci Rep; 2017 Aug; 7(1):9827. PubMed ID: 28851916
[TBL] [Abstract][Full Text] [Related]
2. Cirrhotic Human Liver Extracellular Matrix 3D Scaffolds Promote Smad-Dependent TGF-β1 Epithelial Mesenchymal Transition.
Mazza G; Telese A; Al-Akkad W; Frenguelli L; Levi A; Marrali M; Longato L; Thanapirom K; Vilia MG; Lombardi B; Crowley C; Crawford M; Karsdal MA; Leeming DJ; Marrone G; Bottcher K; Robinson B; Del Rio Hernandez A; Tamburrino D; Spoletini G; Malago M; Hall AR; Godovac-Zimmermann J; Luong TV; De Coppi P; Pinzani M; Rombouts K
Cells; 2019 Dec; 9(1):. PubMed ID: 31905709
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of extracellular matrix in the liver induces high metastatic potential of hepatocellular carcinoma to the lung.
Sawada S; Murakami K; Murata J; Tsukada K; Saiki I
Int J Oncol; 2001 Jul; 19(1):65-70. PubMed ID: 11408924
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
[TBL] [Abstract][Full Text] [Related]
5. Augmented hepatocellular carcinoma progression and depressed Kupffer cell activity in rat cirrhotic livers.
Tsujimoto T; Kuriyama S; Yamazaki M; Nakatani Y; Okuda H; Yoshiji H; Fukui H
Int J Oncol; 2001 Jan; 18(1):41-7. PubMed ID: 11115537
[TBL] [Abstract][Full Text] [Related]
6. Influence of extracellular matrix composition on tumour cell behaviour in a biomimetic in vitro model for hepatocellular carcinoma.
Calitz C; Rosenquist J; Degerstedt O; Khaled J; Kopsida M; Fryknäs M; Lennernäs H; Samanta A; Heindryckx F
Sci Rep; 2023 Jan; 13(1):748. PubMed ID: 36639512
[TBL] [Abstract][Full Text] [Related]
7. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
[TBL] [Abstract][Full Text] [Related]
8. Extracellular matrix collagen I promotes the tumor progression of residual hepatocellular carcinoma after heat treatment.
Zhang R; Ma M; Lin XH; Liu HH; Chen J; Chen J; Gao DM; Cui JF; Ren ZG; Chen RX
BMC Cancer; 2018 Sep; 18(1):901. PubMed ID: 30227844
[TBL] [Abstract][Full Text] [Related]
9. Plasma-derived extracellular matrix for xenofree and cost-effective organoid modeling for hepatocellular carcinoma.
El-Derby AM; Khedr MA; Ghoneim NI; Gabr MM; Khater SM; El-Badri N
J Transl Med; 2024 May; 22(1):487. PubMed ID: 38773585
[TBL] [Abstract][Full Text] [Related]
10. Tumor Microenvironment, a Paradigm in Hepatocellular Carcinoma Progression and Therapy.
Tahmasebi Birgani M; Carloni V
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28216578
[TBL] [Abstract][Full Text] [Related]
11. An extracellular matrix (ECM) model at high malignant colorectal tumor increases chondroitin sulfate chains to promote epithelial-mesenchymal transition and chemoresistance acquisition.
Hoshiba T
Exp Cell Res; 2018 Sep; 370(2):571-578. PubMed ID: 30016638
[TBL] [Abstract][Full Text] [Related]
12. Morphological changes and molecular expressions of hepatocellular carcinoma cells in three-dimensional culture model.
Wu YM; Tang J; Zhao P; Chen ZN; Jiang JL
Exp Mol Pathol; 2009 Oct; 87(2):133-40. PubMed ID: 19615356
[TBL] [Abstract][Full Text] [Related]
13. Diet-Induced Obesity Enhances Progression of Hepatocellular Carcinoma through Tenascin-C/Toll-Like Receptor 4 Signaling.
Benbow JH; Thompson KJ; Cope HL; Brandon-Warner E; Culberson CR; Bossi KL; Li T; Russo MW; Gersin KS; McKillop IH; deLemos AS; Schrum LW
Am J Pathol; 2016 Jan; 186(1):145-58. PubMed ID: 26603137
[TBL] [Abstract][Full Text] [Related]
14. Accelerated orthotopic hepatocellular carcinomas growth is linked to increased expression of pro-angiogenic and prometastatic factors in murine liver fibrosis.
Kornek M; Raskopf E; Tolba R; Becker U; Klöckner M; Sauerbruch T; Schmitz V
Liver Int; 2008 Apr; 28(4):509-18. PubMed ID: 18339078
[TBL] [Abstract][Full Text] [Related]
15. Cell-matrix talks: effects on differentiation of hepatocellular carcinoma.
Wu XZ; Chen D
Minerva Gastroenterol Dietol; 2006 Dec; 52(4):407-13. PubMed ID: 17108870
[TBL] [Abstract][Full Text] [Related]
16. Implication of the Hedgehog pathway in hepatocellular carcinoma.
Della Corte CM; Viscardi G; Papaccio F; Esposito G; Martini G; Ciardiello D; Martinelli E; Ciardiello F; Morgillo F
World J Gastroenterol; 2017 Jun; 23(24):4330-4340. PubMed ID: 28706416
[TBL] [Abstract][Full Text] [Related]
17. Fibrogenic cell fate during fibrotic tissue remodelling observed in rat and human cultured liver slices.
Guyot C; Combe C; Balabaud C; Bioulac-Sage P; Desmoulière A
J Hepatol; 2007 Jan; 46(1):142-50. PubMed ID: 17069927
[TBL] [Abstract][Full Text] [Related]
18. Development of a transgenic mouse model of hepatocellular carcinoma with a liver fibrosis background.
Chung SI; Moon H; Kim DY; Cho KJ; Ju HL; Kim DY; Ahn SH; Han KH; Ro SW
BMC Gastroenterol; 2016 Jan; 16():13. PubMed ID: 26821924
[TBL] [Abstract][Full Text] [Related]
19. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
[TBL] [Abstract][Full Text] [Related]
20. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Tátrai P
Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
